Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

PHAS

PhaseBio Pharmaceuticals (PHAS)

PhaseBio Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PHAS
일자시간출처헤드라인심볼기업
2023/05/3105:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2023/05/2005:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2023/05/2005:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2023/05/2005:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2023/05/2005:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2023/05/1705:23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2023/04/0405:06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2023/03/2421:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2023/02/1507:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2023/02/1505:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2023/02/1504:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/12/2322:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/12/2120:10Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/12/0306:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/11/1606:21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/11/0505:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/11/0106:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/10/2705:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/10/2421:00Business WirePhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy CodeNASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/10/0806:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/09/2901:05TipRanksPhasebio Pharmaceuticals (PHAS) was downgraded to a Hold Rating at NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/09/2806:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/08/1519:15TipRanksH.C. Wainwright Keeps Their Buy Rating on Phasebio Pharmaceuticals (PHAS)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/08/1305:15TipRanksPhasebio Pharmaceuticals (PHAS) Receives a Buy from NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/08/1221:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/08/1221:30Business WirePhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/07/0605:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/06/1621:18TipRanks10 Penny Stocks that Could Deliver Exponential ReturnsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/05/2506:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
2022/05/2506:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:PHAS